Myron Schwartz
Impact in
- Hepatology top 0.01%
- Hepatocellular Carcinoma Treatment and Prognosis
- Liver Disease and Transplantation
- Hepatitis C virus research
- Transplantation top 0.2%
Papers in
- Hepatology 192
- Hepatocellular Carcinoma Treatment and Prognosis 116
- Liver Disease and Transplantation 74
- Hepatitis C virus research 38
-
- Renal Transplantation Outcomes and Treatments 25
- Co-authors
- Sasan RoayaieJosep M. LlovetCharles M. MillerVincenzo MazzaferroSwan N. ThungPatricia A. SheinerSukru EmreParissa Tabrizian
- Journals
- Transplantation (31 papers)Hepatology (15 papers)Journal of Hepatology (15 papers)Gastroenterology (12 papers)HPB (12 papers)
- Partner nations
- United StatesSpainItaly
In The Last Decade
Myron Schwartz
324 papers receiving 20.5k citations
Hit Papers
Peers
Comparison fields: 5 of 150
- Hepatology 12.9k
- Transplantation 892
- Cancer Research 3.2k
- Epidemiology 6.9k
- Surgery 7.4k
Countries citing papers authored by Myron Schwartz
This map shows the geographic impact of Myron Schwartz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Myron Schwartz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Myron Schwartz more than expected).
Fields of papers citing papers by Myron Schwartz
This network shows the impact of papers produced by Myron Schwartz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Myron Schwartz. The network helps show where Myron Schwartz may publish in the future.
Co-authors
The 25 scholars most cited alongside Myron Schwartz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Adjuvant and neoadjuvant immunotherapies in hepatocellular carcinoma Hit paper breakdown → | 2024 | 162 |
| 2 | 2024 | 6 | |
| 3 | 2024 | 41 | |
| 4 | 2023 | 6 | |
| 5 | 2023 | 32 | |
| 6 | 2021 | 16 | |
| 7 | 2021 | 3 | |
| 8 | 2020 | 99 | |
| 9 | 2020 | 127 | |
| 10 | 2020 | 82 | |
| 11 | 2017 | 45 | |
| 12 | 2016 | 7 | |
| 13 | 2016 | 43 | |
| 14 | 2015 | 90 | |
| 15 | 2012 | 230 | |
| 16 | 2011 | 171 | |
| 17 | 2011 | 312 | |
| 18 | Genome‐wide molecular profiles of HCV‐induced dysplasia and hepatocellular carcinoma† Hit paper breakdown → | 2007 | 559 |
| 19 | Dysregulation of hedgehog pathway signaling in hepatocellular carcinoma | 2006 | 0 |
| 20 | Long-Term Results With Multimodal Adjuvant Therapy and Liver Transplantation for the Treatment of Hepatocellular Carcinomas Larger Than 5 Centimeters | 2002 | 4 |
About Myron Schwartz
Myron Schwartz is a scholar working on Hepatology, Transplantation, Surgery, Epidemiology and Oncology, having authored 328 papers that have together received 20.9k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (116 papers), Liver Disease Diagnosis and Treatment (81 papers), Organ Transplantation Techniques and Outcomes (77 papers), Liver Disease and Transplantation (74 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (55 papers), Hepatitis C virus research (38 papers), Hepatitis B Virus Studies (31 papers) and Renal Transplantation Outcomes and Treatments (25 papers). The work is most often cited by research in Hepatology (12.9k citations), Transplantation (892 citations), Cancer Research (3.2k citations), Epidemiology (6.9k citations) and Surgery (7.4k citations). Myron Schwartz has collaborated with scholars based in United States, Spain and Italy. Frequent co-authors include Sasan Roayaie, Josep M. Llovet, Charles M. Miller, Vincenzo Mazzaferro, Swan N. Thung, Patricia A. Sheiner, Sukru Emre, Parissa Tabrizian, Jordi Bruix and Max W. Sung. Their work appears in journals such as Transplantation, Hepatology, Journal of Hepatology, Gastroenterology and HPB.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.